(Q39500087)

English

Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease--a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms)

scientific article published on September 1, 1992

Statements

Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease--a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms) (English)
0 references
1 September 1992
409-417

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit